ADMA Biologics, Inc. EPS (Earnings per Share) 2011–2025
ADMA Biologics, Inc. reported $0.60 of earnings per share for fiscal 2025. That was 25.9% lower than fiscal 2024. Compared with fiscal 2020, the change was +168.2%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $0.60 | -25.9% |
| FY 2024 | $0.81 | +723.1% |
| FY 2023 | $-0.13 | +60.6% |
| FY 2022 | $-0.33 | +35.3% |
| FY 2021 | $-0.51 | +42.0% |
| FY 2020 | $-0.88 | — |
| FY 2019 | $0.00 | — |
| FY 2018 | $0.00 | — |
| FY 2017 | $0.00 | — |
| FY 2016 | $0.00 | — |
| FY 2015 | $0.00 | — |
| FY 2014 | $0.00 | — |
| FY 2013 | $0.00 | — |
| FY 2012 | $0.00 | — |
| FY 2011 | $0.00 | — |
Source: ADMA Biologics, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ADMA 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
ADMA Biologics, Inc. reported $0.60 of earnings per share for fiscal 2025. That was 25.9% lower than fiscal 2024. Compared with fiscal 2020, the change was +168.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for ADMA Biologics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeADMA Biologics, Inc. — frequently asked questions
What is ADMA Biologics, Inc.'s earnings per share?
ADMA Biologics, Inc. (ADMA) reported earnings per share of $0.60 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from ADMA Biologics, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.